nasdaq:amph
|
674681
|
Apr 21st, 2024 12:00AM
|
Amphastar Pharmaceuticals, Inc.
|
5.0K
|
360.00
|
Open
|
|
Apr 20th, 2024 10:51PM
|
Apr 20th, 2024 10:51PM
|
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.
As a commitment to high quality, all Amphastar finished products are manufactured in the United States.
|
Open
|
pharmaceutical, injectable products, and inhalation products
|
Open
|
11570 Sixth Street
|
Rancho Cucamonga
|
California
|
US
|
91730
|
|
Amphastar Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:amph
|
674681
|
Apr 20th, 2024 12:00AM
|
Amphastar Pharmaceuticals, Inc.
|
5.0K
|
360.00
|
Open
|
|
Apr 19th, 2024 10:42PM
|
Apr 20th, 2024 04:32PM
|
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.
As a commitment to high quality, all Amphastar finished products are manufactured in the United States.
|
Open
|
pharmaceutical, injectable products, and inhalation products
|
Open
|
11570 Sixth Street
|
Rancho Cucamonga
|
California
|
US
|
91730
|
|
Amphastar Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:amph
|
674681
|
Apr 19th, 2024 12:00AM
|
Amphastar Pharmaceuticals, Inc.
|
5.0K
|
360.00
|
Open
|
|
Apr 18th, 2024 10:50PM
|
Apr 18th, 2024 10:50PM
|
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.
As a commitment to high quality, all Amphastar finished products are manufactured in the United States.
|
Open
|
pharmaceutical, injectable products, and inhalation products
|
Open
|
11570 Sixth Street
|
Rancho Cucamonga
|
California
|
US
|
91730
|
|
Amphastar Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:amph
|
674681
|
Apr 18th, 2024 12:00AM
|
Amphastar Pharmaceuticals, Inc.
|
5.0K
|
360.00
|
Open
|
|
Apr 17th, 2024 10:54PM
|
Apr 18th, 2024 05:52PM
|
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.
As a commitment to high quality, all Amphastar finished products are manufactured in the United States.
|
Open
|
pharmaceutical, injectable products, and inhalation products
|
Open
|
11570 Sixth Street
|
Rancho Cucamonga
|
California
|
US
|
91730
|
|
Amphastar Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:amph
|
674681
|
Apr 17th, 2024 12:00AM
|
Amphastar Pharmaceuticals, Inc.
|
5.0K
|
360.00
|
Open
|
|
Apr 16th, 2024 10:38PM
|
Apr 17th, 2024 02:15PM
|
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.
As a commitment to high quality, all Amphastar finished products are manufactured in the United States.
|
Open
|
pharmaceutical, injectable products, and inhalation products
|
Open
|
11570 Sixth Street
|
Rancho Cucamonga
|
California
|
US
|
91730
|
|
Amphastar Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:amph
|
674681
|
Apr 16th, 2024 12:00AM
|
Amphastar Pharmaceuticals, Inc.
|
5.0K
|
360.00
|
Open
|
|
Apr 15th, 2024 10:38PM
|
Apr 16th, 2024 10:32AM
|
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.
As a commitment to high quality, all Amphastar finished products are manufactured in the United States.
|
Open
|
pharmaceutical, injectable products, and inhalation products
|
Open
|
11570 Sixth Street
|
Rancho Cucamonga
|
California
|
US
|
91730
|
|
Amphastar Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:amph
|
674681
|
Apr 15th, 2024 12:00AM
|
Amphastar Pharmaceuticals, Inc.
|
5.0K
|
358.00
|
Open
|
|
Apr 14th, 2024 10:39PM
|
Apr 15th, 2024 04:13PM
|
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.
As a commitment to high quality, all Amphastar finished products are manufactured in the United States.
|
Open
|
pharmaceutical, injectable products, and inhalation products
|
Open
|
11570 Sixth Street
|
Rancho Cucamonga
|
California
|
US
|
91730
|
|
Amphastar Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:amph
|
674681
|
Apr 14th, 2024 12:00AM
|
Amphastar Pharmaceuticals, Inc.
|
5.0K
|
358.00
|
Open
|
|
Apr 13th, 2024 10:34PM
|
Apr 13th, 2024 10:34PM
|
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.
As a commitment to high quality, all Amphastar finished products are manufactured in the United States.
|
Open
|
pharmaceutical, injectable products, and inhalation products
|
Open
|
11570 Sixth Street
|
Rancho Cucamonga
|
California
|
US
|
91730
|
|
Amphastar Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:amph
|
674681
|
Apr 13th, 2024 12:00AM
|
Amphastar Pharmaceuticals, Inc.
|
5.0K
|
358.00
|
Open
|
|
Apr 12th, 2024 10:24PM
|
Apr 13th, 2024 11:00AM
|
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.
As a commitment to high quality, all Amphastar finished products are manufactured in the United States.
|
Open
|
pharmaceutical, injectable products, and inhalation products
|
Open
|
11570 Sixth Street
|
Rancho Cucamonga
|
California
|
US
|
91730
|
|
Amphastar Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:amph
|
674681
|
Apr 12th, 2024 12:00AM
|
Amphastar Pharmaceuticals, Inc.
|
5.0K
|
358.00
|
Open
|
|
Apr 11th, 2024 10:27PM
|
Apr 12th, 2024 07:55AM
|
Amphastar Pharmaceuticals is a recognized pharmaceutical company that uses state-of-the-art, cGMP-compliant facilities to develop, manufacture, and market biopharmaceutical injectable, intranasal, and inhalation products.
In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities in the United States, China, and Europe, along with a state-of-the-art New Drug Research Center.
As a commitment to high quality, all Amphastar finished products are manufactured in the United States.
|
Open
|
pharmaceutical, injectable products, and inhalation products
|
Open
|
11570 Sixth Street
|
Rancho Cucamonga
|
California
|
US
|
91730
|
|
Amphastar Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|